Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal Oniris

Home page

COLISEE

COLISEE
Control of avian colibacillosis in broiler farms

Context and objectives

Colibacillosis is one of the most common diseases in poultry, involving significant economic losses and the use of antibiotics. The Escherichia coli bacterium has a wide variety of strains and virulence factors, making it difficult to characterise and control the disease.

The three parts of the COLISEE study will be conducted from 2017 to 2019:

  • Part 1 : Epidemiological study in 100 chicken farms to identify the factors that trigger colibacillosis and to study the relationship between the molecular profiles of E.Coli strains and epidemiological-clinical data. Given the frequent association between E.Coli and Enterococcus, especially in the case of locomotor disorders, isolation of Enterococcus strains will also be carried out.
  • Part 2 : Development of tools for the characterization of E.coli strains isolated in farms (PCR and MALDI-TOF).
  • Part 3: Development of colibacillosis models and vaccination trials using isolated strains.

Recruitment of the 100 chicken farms

The study will be carried out in 100 batches of broilers from the Great West of France over a period of 18 months. It is planned to have 5 participating organisations with 20 flocks per organisation spread over the 18 months (i.e. 1 to 2 flocks/organisation per month). Recruitment is based on the voluntary work of the breeders and production organisations.

Criteria for the inclusion of lots :
- Chickens of Ross PM3, Ross 308 and Cobb strains
- Lots vaccinated against Infectious Bronchitis and Gumboro disease.
- Located close to a partner laboratory of the study
- Set up in the morning (Tuesday or Wednesday)

Financing of the study and reporting of results

The study is funded by the Ministry of Agriculture, Agri-Food and Forestry (CASDAR) and the CPIC. The cost of bacteriological analyses is covered by the study, except in cases of suspected colibacillosis for which the lesions do not meet the criteria.

As soon as the analyses are carried out, the results will be returned to the organisation's technicians and to the breeders by the laboratories. Technical and scientific communications will also provide all the results of the study.

People involved in BIOEPAR : Florence Beaugrand - Mily Leblanc-Maridor

Financing of the study and reporting of results